Topical Crisaborole in the Treatment of Atopic Hand Dermatitis: A Retrospective Chart Review

Halling-Overgaard AS , Zachariae C , Thyssen JP . Management of atopic hand dermatitis. Dermatol Clin, 2017; 35(3):–.

Paller AS , Tom WL , Lebwohl MG , et al. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol, 2016; 75(3):494–503.e6. doi:.

PubChem. National Center for Biotechnology Information. PubChem Compound Database. US National Library of Medicine. Available at: http://www.pubchem.ncbi.nlm.nih.gov/. Accessed August 25, 2020.

Fantini A , Demurtas A , Nicoli S , et al. In vitro skin retention of crisaborole after topical application. Pharmaceutics, 2020; 12(6):491. doi:.